diflucortolone


Also found in: Wikipedia.

diflucortolone

 [di-floo-kor´tah-lōn]
a synthetic corticosteroid used as the valerate salt and applied topically in treatment of inflammation and pruritus of dermatoses.

diflucortolone

/di·flu·cor·to·lone/ (di″floo-kor´tah-lōn″) a synthetic corticosteroid used topically as the valerate salt for the relief of inflammation and pruritus in corticosteroid-responsive dermatoses.

diflucortolone

[diflo̅o̅kor′tählōn]
a synthetic corticosteroid used as the valerate salt and applied topically in treatment of inflammation and pruritus of dermatoses.
References in periodicals archive ?
5% hydrocortisone Cream, ointment Low potency 1% hydrocortisone Cream, ointment Moderate potency Beclomethasone dipropionate Cream Clobctasonc butyrate Cream Fluticasone propionate Cream, ointment Hydrocortisone 17-bulyrate Cream, lipocream, ointment, lotion, emulsifying lotion Methylprednisolone acetonate 1% Milk, scalp solution, cream, ointment, fatty ointment Mometasone furoate Cream, ointment, lotion Potent Betamethasone valerate Cream, ointment, solution, scalp solution Fluocinolone acetonide Cream, ointment, gel Diflucortolone valerate Cream, fatty ointment, forte Very potent ointment Clobetasol propionate Cream, ointment, shampoo, scalp solution Belhamelasone dipropionate Cream, ointment Table 3.
3 mg / 1 g 5 12 Drugs and reagents for laboratory DIFLUCORTOLONE S krem 1 mg / 1 g 10 13 Drugs and reagents for laboratory STREPTOMYCIN amp 1g 50 14 Drugs and reagents for laboratory ETILEFRINE amp 10mg/1ml 100 15 Drugs and reagents for laboratory CYANOCOBALAMIN amp 100mcg/1ml 400 16 Drugs and reagents for laboratory CHLOROPYRAMINE amp 20mg/2ml 70 17 Drugs and reagents for laboratory ATROPINE Amp 0,50 mg / 1,00 ml 50 18 Drugs and reagents for laboratory AMINOPHYLLINE amp 250mg/10ml 50 19 Drugs and reagents for laboratory MANNITOL in.
1% diflucortolone valerate cream, the periods of pre-treatment (3 to 14 days) and follow-up treatment (3 to 4 weeks) were of differing duration and the sizes of the comparator populations were different (72, 58, and 31 patients respectively) (Aertgeerts, 1985).